Skip to main content
PFE
NYSE Life Sciences

Generic Tofacitinib Launches, Threatening Pfizer's Xeljanz; Company Licenses AI for Drug Discovery

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$25.72
Mkt Cap
$146.419B
52W Low
$23.08
52W High
$28.745
52W Position info
11% above low
Off High info
11% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.08 (11% above the low).

Summary

Breckenridge has launched a generic version of tofacitinib, directly competing with Pfizer's blockbuster drug Xeljanz. This generic entry will immediately pressure Xeljanz sales, which were a significant revenue driver for Pfizer. Separately, Pfizer licensed Chai Discovery's AI platform to accelerate its drug discovery efforts, a positive long-term strategic move to enhance R&D efficiency. However, the immediate financial impact of generic competition for Xeljanz is expected to be a material headwind for the company.

At the time of this announcement, PFE was trading at $25.72 on NYSE in the Life Sciences sector, with a market capitalization of approximately $146.4B. The 52-week trading range was $23.08 to $28.75. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 18, 2026, 7:20 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.28
Real-time Price: $27.95 info
Change: -$0.330 (-1%) info
Market Cap: $159.254B info
PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $27.95 info
Change: -$1.17 (-4%) info
Market Cap: $159.254B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $27.95 info
Change: -$0.9025 (-3%) info
Market Cap: $159.254B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $27.95 info
Change: -$1.50 (-5%) info
Market Cap: $159.254B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $27.95 info
Change: -$2.71 (-9%) info
Market Cap: $159.254B info